Financhill
Sell
40

CUE Quote, Financials, Valuation and Earnings

Last price:
$1.06
Seasonality move :
-5.06%
Day range:
$0.98 - $1.06
52-week range:
$0.45 - $3.20
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.25x
P/B ratio:
2.52x
Volume:
139.3K
Avg. volume:
452.7K
1-year change:
-66.22%
Market cap:
$64M
Revenue:
$5.5M
EPS (TTM):
-$0.91

Earnings Data

Next earnings date for CUE
Apr 08
2025
Most recent earnings per share
-$0.17
Beat by $0.02
(Nov 14/2024)
Consensus Estimate
-$0.19
(Nov 14/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CUE Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
12/31/2024 Q4 $1.7M -- -- -$0.15 --
11/14/2024 Q3 $1.5M $3.3M -$0.17 -$0.19 $0.02
08/19/2024 Q2 $1.3M $2.7M -$0.20 -$0.28 $0.08
05/09/2024 Q1 $1.2M $1.7M -$0.25 -$0.29 $0.04
03/21/2024 Q4 $1.6M $1.8M -$0.29 -$0.28 -$0.01
11/09/2023 Q3 -- -- -$0.24 -$0.34 $0.10
08/09/2023 Q2 -- -- -$0.29 -$0.31 $0.02
05/09/2023 Q1 -- -- -$0.29 -$0.29 --
03/21/2023 Q4 -- -- -$0.38 -$0.31 -$0.07
11/14/2022 Q3 -- -- -$0.31 -$0.38 $0.07
08/04/2022 Q2 -- -- -$0.37 -$0.40 $0.03
05/10/2022 Q1 -- -- -$0.44 -$0.42 -$0.02
03/16/2022 Q4 -- -- -$0.25 -$0.41 $0.16
11/09/2021 Q3 -- -- -$0.41 -$0.37 -$0.04
08/17/2021 Q2 -- -- -$0.33 -$0.40 $0.07
05/17/2021 Q1 -- -- -$0.41 -$0.36 -$0.06
03/16/2021 Q4 -- -- -$0.36 -$0.35 -$0.01
11/17/2020 Q3 -- -- -$0.34 -$0.38 $0.04
08/31/2020 Q2 -- -- -$0.38 -$0.43 $0.05
05/19/2020 Q1 -- -- -$0.48 -$0.37 -$0.11
03/17/2020 Q4 -- -- -$0.37 -$0.44 $0.07
11/12/2019 Q3 -- -- -$0.31 -$0.44 $0.13
08/08/2019 Q2 -- -- -$0.46 -$0.56 $0.10
05/08/2019 Q1 -- -- -$0.54 -$0.40 -$0.14
03/14/2019 Q4 -- -- -$0.58 -$0.40 -$0.18
11/13/2018 Q3 -- -- -$0.62 -- --
08/13/2018 Q2 -- -- -$0.36 -- --
05/14/2018 Q1 -- -- -$0.37 -- --
12/31/2017 Q4 -- -- -$0.51 -- --
09/30/2017 Q3 -- -- -$0.24 -- --
06/30/2017 Q2 -- -- -$0.21 -- --
03/31/2017 Q1 -- -- -$0.16 -- --
12/31/2016 Q4 -- -- -$0.14 -- --
09/30/2016 Q3 -- -- -$0.10 -- --

Cue Biopharma Earnings Questions

  • How Much did Cue Biopharma Generate in Revenue Last Quarter?

    Cue Biopharma reported $3.3M worth of top line sales in its most recent quarter.

  • Did Cue Biopharma Beat Earnings Last Quarter?

    Cue Biopharma announced earnings per share of -$0.17 which represents a beat of analyst forecast a -$0.19 per share.

  • Is Cue Biopharma Profitable?

    Cue Biopharma reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Cue Biopharma EPS Next Year?

    Cue Biopharma's earnings are forecast to decrease from -$1.11 per share to -$1.16 per share next year representing a decrease of -31.98%.

  • When is Cue Biopharma's Earnings Date?

    Cue Biopharma's next earnings date is April 8, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is SoundHound AI Stock Up So Much?
Why Is SoundHound AI Stock Up So Much?

Like many companies improving AI technologies and exploring ways to…

Is The Santa Claus Rally The Gift That Keeps Giving?
Is The Santa Claus Rally The Gift That Keeps Giving?

Remember the horror of 2008 when the Great Recession hit…

Is Alphabet an Undervalued Growth Stock to Buy?
Is Alphabet an Undervalued Growth Stock to Buy?

Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 118x

Buy
58
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
87
PSIX alert for Dec 26

Power Solutions International [PSIX] is down 10.34% over the past day.

Buy
65
TSLL alert for Dec 26

Direxion Daily TSLA Bull 2X Shares [TSLL] is down 0.74% over the past day.

Buy
75
SMLR alert for Dec 26

Semler Scientific [SMLR] is down 2.82% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock